NCT03562728View on ClinicalTrials.gov

Progressive Rehabilitation Therapy in Patients With Advanced Lung Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 13, 2019

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2027

Conditions
Advanced Lung DiseaseLung TransplantExtracorporeal Membrane Oxygenation
Interventions
DEVICE

MRP and NMES(neuromuscular electric stimulation)

nutrition supplementation includes addition of essential amino acids 3 times a day to feeding

OTHER

Standard of Care

Patients in the control group are going to receive standard of care

Trial Locations (1)

21201

University of Maryland, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT03562728 - Progressive Rehabilitation Therapy in Patients With Advanced Lung Disease | Biotech Hunter | Biotech Hunter